Multiple pterygium-malignant hyperthermia syndrome Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

1 event

Jul 2014

RYANODEX: FDA approved

Treatment of malignant hyperthermia in conjunction with appropriate supportive measures and for the prevention of malignant hyperthermia in patients at high risk.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance1

RYANODEX

Eagle Pharmaceuticals, Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

RYANODEX

(dantrolene sodium suspension for injection)Orphan drug

Eagle Pharmaceuticals, Inc.

12.1 Mechanism of Action In isolated nerve-muscle preparation, dantrolene has been shown to produce relaxation by affecting the contractile response o...

Approved Jul 2014FDA label ↗

View full treatment details on disease page →